ArticleMolecular oncology2022
Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma.
Kaidong Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it